Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 901–1,000 of 1,000
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model
Caredio, D., Mariutti, G., Polzer, L. K., Gatta, B., Cerisoli, M., Laimeche, Y., Miracca, G., Droux, J., Amki, M. E., Emmenegger, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73003-5 · Cited by 6
Linking aging and animal models to neurodegeneration
Ureshino, R. P., & López, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818000-6.00048-2 · Cited by 5
The biological basis of Parkinson's disease: A comprehensive review
Guessoum, A., Abouelsoud, M., & Khirani, I. (2024) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2024.12.2.1473 · Cited by 5
Environmental pollutants and alpha-synuclein toxicity in Parkinson’s disease
Roy, S., Kakoty, V., Sahebkar, A., Md, S., & Kesharwani, P. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155605 · Cited by 5
Daida, K., Funayama, M., Li, Y., Yoshino, H., Hayashida, A., Ikeda, A., Ogaki, K., Nishioka, K., & Hattori, N. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.576465 · Cited by 5
Rahul, R., & Siddique, Y. H. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210903101841 · Cited by 5
Alam, R., Biswas, S., Haque, F., Pathan, M. T., Imon, R. R., Talukder, M. E. K., Samad, A., Asseri, A. H., & Ahammad, F. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103183 · Cited by 5
Sriram, N., Holla, V. V., Kumari, R., Kamble, N. L., Saini, J. S., Mahale, R. R., Netravathi, M., Padmanabha, H., Gowda, V. K., Battu, R., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105409 · Cited by 5
Modeling familial and sporadic Parkinson's disease in small fishes
Yamanaka, T., & Matsui, H. (2023) · Development Growth & Differentiation · doi:10.1111/dgd.12904 · Cited by 5
Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
Gleave, J. A., Perri, P. D., & Nash, J. E. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1337-8 · Cited by 5
The Lysosome in Aging‐Related Neurodegenerative Diseases
Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch9 · Cited by 7
Emerging Roles of Mitochondrial Serine Protease HtrA2 in Neurodegeneration
Wagh, A. R., & Bose, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-2513-6_15 · Cited by 6
PET Molecular Imaging in Familial Parkinson's Disease
Matarazzo, M., Wile, D. J., Mackenzie, M., & Stoessl, A. J. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.003 · Cited by 5
Role of Genes and Treatments for Parkinson’s Disease
Naz, F., & Siddique, Y. H. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010047 · Cited by 5
Gopurappilly, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_643 · Cited by 5
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00001-0 · Cited by 5
Genetics of Parkinson's Disease
Ross, O. A., Braithwaite, A. T., & Farrer, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00002-6 · Cited by 7
Ipsen, J. Ø., & Sørensen, D. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274908 · Cited by 5
Eye movements in genetic parkinsonisms affecting the α-synuclein, PARK9, and manganese network
Pretegiani, E., Rosini, F., Federico, A., Optican, L. M., & Rufa, A. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.09.107 · Cited by 5
Preventing Parkinson’s pathology
DeSantis, M. E., & Dersh, D. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005678 · Cited by 5
Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what’s in a name?
de Bot, S. T., Kamsteeg, E., & van de Warrenburg, B. P. C. (2017) · Brain · doi:10.1093/brain/awx280 · Cited by 5
Korczyn, A. D., Balash, Y., & Gurevich, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00323-4 · Cited by 5
Zou, Z., Zhou, J., Lu, Y., Huang, Y., Zhou, L., Wang, X., Chen, J., Tian, H., Ge, X., Guo, C., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534066123 · Cited by 4
Solla, P., Cannas, A., Floris, G., Murru, M. R., Corongiu, D., Tranquilli, S., Cuccu, S., Rolesu, M., Marrosu, F., & Marrosu, M. G. (2010) · Parkinson s Disease · doi:10.4061/2010/537698 · Cited by 4
[Autophagy pathways and key drug targets in Parkinson's disease].
Ouyang, L., Zhang, L., & Liu, B. (2016) · PubMed · Cited by 4
Transporter proteins and its implication in human diseases
Kabra, R., & Singh, S. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2020.08.004 · Cited by 4
Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution
Jagota, P., Ugawa, Y., Aldaajani, Z., Ibrahim, N. M., Ishiura, H., Nomura, Y., Tsuji, S., Diesta, C. C. E., Hattori, N., Onodera, O., et al. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.23065 · Cited by 4
Self-citationEmerging parkinsonian phenotypes
Elia, A. E., & Albanese, A. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.017 · Cited by 6
Muñoz, P., Meléndez, C., Paris, I. B., & Segura‐Aguilar, J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_11 · Cited by 6
Exosomes: Cellular capsules for drug delivery in Parkinson’s disease
Samal, J., Demir, S., & Pandit, A. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50922-0.00006-7 · Cited by 5
Iron Metabolism and Related Disorders
Ginzburg, Y. Z., & Finberg, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00012-1 · Cited by 4
Hasnain, M. J. U., Amin, F., Ghani, A., Ahmad, S., Rahman, Z. U., Aslam, T., & Pervez, M. T. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3118054 · Cited by 4
Mutation analysis of the ATP13A2 gene in patients with PD and MSA from Italy
Gagliardi, M., Procopio, R., Nicoletti, G., Morelli, M., Brighina, L., Quattrone, A., Bonapace, G., Malanga, D., Quattrone, A., & Annesi, G. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120031 · Cited by 4
Nezu, M., Hirotsu, Y., Amemiya, K., Tateno, T., Takizawa, S., Inoue, M., Mochizuki, H., Hosaka, K., Chik, C. L., Oyama, T., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0743-22 · Cited by 4
Zhang, X., Zhen, D., Li, X., Yi, F., Zhang, Z., Yang, W., Li, X., Sheng, Y., Liu, X., Jin, T., et al. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s404438 · Cited by 4
Rahman, M. M., Sarker, M. T., Ahmed, S., Uddin, M. N., Islam, M. S., Islam, M. R., Das, S., Mukherjee, N., Hemeg, H. A., Rauf, A., et al. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.07.007 · Cited by 4
Preserved cardiac 123I‐MIBG uptake and lack of severe autonomic dysfunction in a PARK9 patient
Kanai, K., Asahina, M., Arai, K., Tomiyama, H., Kuwabara, Y., Uchiyama, T., Sekiguchi, Y., Funayama, M., Kuwabara, S., Hattori, N., et al. (2009) · Movement Disorders · doi:10.1002/mds.22520 · Cited by 4
Dasouki, M., & El‐Shanti, H. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_11 · Cited by 5
Santano, C., de Lara, M. P., & Pintor, J. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_10 · Cited by 6
Genetic analysis of the ATP1B4 gene in Chinese Han patients with Parkinson’s disease
Gao, K., Song, Z. J., Liang, H. W., Zheng, W., Deng, X., Yuan, Y., Zhao, Y., & Deng, H. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3084-y · Cited by 4
Fitzmaurice, A. G. (2012) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/fdag-hh02 · Cited by 16
Generative modeling for RNA splicing predictions and designPreprint
Wu, D., Maus, N., Jha, A., Yang, K., Wales-McGrath, B. D., Jewell, S., Tangiyan, A., Choi, P. S., Gardner, J. R., & Barash, Y. (2025) · eLife · doi:10.7554/elife.106043.1 · Cited by 8
Generative modeling for RNA splicing prediction and designPreprint
Wu, D., Maus, N., Jha, A., Yang, K., Wales-McGrath, B. D., Jewell, S., Tangiyan, A., Choi, P. S., Gardner, J. R., & Barash, Y. (2025) · eLife · doi:10.7554/elife.106043.2 · Cited by 4
Maladies neurodégénératives et stress oxydant
Lévy, E. (2020) · theses.fr (ABES) · doi:10.70675/75371581z194fz4cb4zb457z91bf72dc0320 · Cited by 4
Supranuclear Vertical Gaze Palsy in Movement Disorders
Salari, M., Alikhani, A., Hojjatipour, F., & Etemadifar, M. (2024) · Neuro-Ophthalmology · doi:10.1080/01658107.2024.2379423 · Cited by 3
Keleş, B. S., Rumman, B., Samarie, M. A. J. A., Özdemir, Y., Çakmak, Ö. Ö., Akyoldaş, G., Ertan, S., & Sokullu, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02461-z · Cited by 4
Mitochondrial Degradation, Autophagy and Neurodegenerative Disease
Otten, E. G., Manni, D., & Korolchuk, V. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_11 · Cited by 5
Parkinson's Disease: Clinical Manifestations and Risk Factors
Echchakery, M., Guennouni, M., Amane, M., Omari, M., Baz, S. E., Achbani, A., Draoui, A., Aimrane, A., Otmani, I. E., Rokni, T., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch008 · Cited by 3
Generative modeling for RNA splicing prediction and design
Wu, D., Maus, N., Jha, A., Yang, K., Wales-McGrath, B. D., Jewell, S., Tangiyan, A., Choi, P. S., Gardner, J. R., & Barash, Y. (2026) · eLife · doi:10.7554/elife.106043.3 · Cited by 3
Neurodegeneration with Brain Iron Accumulation
Schipper, D. A., & Schipper, H. M. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_19 · Cited by 4
Carrillo, F., & Mir, P. (2012) · InTech eBooks · doi:10.5772/18648 · Cited by 3
Genes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
Inflammasome-Mediated Inflammation in Neurodegenerative Diseases
Park, J. Y., Kang, Y. W., & Cho, W. G. (2019) · The Open Neurology Journal · doi:10.2174/1874205x01913010055 · Cited by 4
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411573-6.00015-2 · Cited by 3
Kim, Y. J., Lee, J., Kim, N. Y., Hong, S., Cho, Y. S., & Yoon, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.11.011 · Cited by 3
Measurement of GCase Activity in Cultured Cells
Shojima, Y., Ogata, J., Tsunemi, T., Imai, Y., & Hattori, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1495-2_5 · Cited by 3
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?
Petese, A., Cesaroni, V., Cerri, S., & Blandini, F. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210809123630 · Cited by 3
Fernández‐Espejo, E., Gavito, A., Suárez, J., TOLOSA, E. S., Vilas, D., Aldecoa, I., Berenguer, J., Córdoba-Fernández, A., Damas-Hermoso, F., & de Fonseca, F. R. (2022) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2022.100163 · Cited by 3
Parkinson’s Disease: A Comprehensive Overview of the Disease
Khatib, A. J. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109437 · Cited by 4
Fittipaldi, S., Báez, S., Gonzalez‐Silva, C., & Duran-Aniotz, C. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1168414 · Cited by 4
The Genetics of Parkinson’s Disease
YÜCEL, Z., Şimşek, L., & YÜKSEL, E. B. (2024) · Genel Tıp Dergisi · doi:10.54005/geneltip.1337447 · Cited by 3
Sex differences impact serum metabolome profiles in patients with familial Parkinson’s disease
Marino, C., Carrillo, F., Serra, M., Nuzzo, T., Vidali, M., Pietracupa, S., Modugno, N., Grimaldi, M., Errico, F., D’Ursi, A. M., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01511-8 · Cited by 3
Rapid genetic diagnosis in single‐gene movement disorders
Singleton, A. (2012) · Movement Disorders · doi:10.1002/mds.24896 · Cited by 3
Genetic aspects of Parkinson's disease
Mizuno, Y., Hattori, N., & Mochizuki, H. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83009-0 · Cited by 3
Weng, Y., Chen, C., Chen, Y. C., Fung, H., Chang, C. W., Chang, K. H., & Wu, Y. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.07.020 · Cited by 3
West, A. B., Gray, M., & Standaert, D. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00123-3 · Cited by 3
Neurodegeneration with brain iron accumulation
Schneider, S. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00046-5 · Cited by 3
Genetics of Parkinson's Disease—An Overview
Klein, C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00002-7 · Cited by 3
Wiethoff, S., Bhatia, K. P., & Houlden, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_13 · Cited by 3
Korczyn, A. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00028-9 · Cited by 3
Lee, Y. J., Syed, K. M., Busquets, O., Li, H., Dunnack, J., Bateup, H. S., Soldner, F., Hockemeyer, D. F., & Rio, D. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582420 · Cited by 3
Shonai, D., Kent, J. K., Okafor, A. E., Gao, Y., Parameswaran, P., Bustamante, E., Ramani, B., Diao, Y., Kampmann, M., Soderblom, E. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.699530 · Cited by 4
Genetics of Metal Disorders (Excluding NBIA)
Dušek, P., & Záhoráková, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_14 · Cited by 2
Genetic Sketch of Parkinson’s Disease in India
Bhowmick, S. S., & Desai, S. (2025) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_1021_24 · Cited by 3
Mordà, D., Alibrandi, S., Scimone, C., Rinaldi, C., Scalinci, S. Z., Abate, G., D’Angelo, R., Sidoti, A., & Donato, L. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101405 · Cited by 2
Vinogradov, E., Edri, B., Ravkaie, L., Lazarescu, O., Gharra, F., Jubran, J., Ben‐Zvi, A., & Yeger‐Lotem, E. (2025) · Autophagy · doi:10.1080/15548627.2025.2580035 · Cited by 2
Minimal-tag polyamines for in situ probing of their intracellular distribution
Sas, Z., Zakrzewski, M., Wardak, A. D., Wanat, P., Czestkowski, W., Zmorzyńska, J., Marusiak, A. A., & Serwa, R. A. (2025) · Chemical Communications · doi:10.1039/d5cc06304c · Cited by 2
Marcos, A., Gironacci, M. M., & Pinto, F. D. T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010484 · Cited by 2
Belickienė, V., Pranckevičienė, A., Radžiūnas, A., Strigauskaitė, A., Laucius, O., & Vaitkienė, P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70355 · Cited by 2
Polyamine homeostasis in Caenorhabditis elegans relies primarily on transport
Chang, C., & Jain, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117283 · Cited by 2
The role of energy deficit in autophagy failure in Parkinson’s disease
Bošnjak, M., Misirkic-Marjanovic, M., Kosić, M., Mandić, M., Vucicevic, L. M., Paunović, V., & Harhaji-Trajkovic, L. M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1846307 · Cited by 2
TSUKIBOSHI, K., Ishikawa, K., Yamaguchi, A., Arai, K., Kanai, K., Tsunemi, T., Okano, H., Hattori, N., & Akamatsu, W. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70515 · Cited by 2
Lysosomal dysfunction in neurodegenerative disease
Brooker, S. M., Coukos, R., & Krainc, D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01262-3 · Cited by 2
Küpper, C., Levin, J., & Klopstock, T. (2017) · Neuroradiologie Scan · doi:10.1055/s-0043-103529 · Cited by 2
Ataxia and Action Myoclonus Related to Novel Mutations in ATP13A2 Gene
Manrique, L., Sánchez‐Rodríguez, A., Pelayo‐Negro, A. L., Corral‐Juan, M., Matilla‐Dueñas, A., & Infante, J. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13260 · Cited by 2
Update on the etiology and pathogenesis of muscle dystonia
Bushueva, O. O., & Антипенко, Е. А. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2021121041127 · Cited by 2
YPK9 and WHI2 Negatively Interact during Oxidative Stress
Joseph, F., Miller, D., Evgrafov, O. V., & Chirico, W. J. (2021) · Microorganisms · doi:10.3390/microorganisms9122584 · Cited by 2
Autophagy and Parkinson’s Disease
Ryan, L., Rob, M., He, J., & Rubinsztein, D. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_242 · Cited by 4
D’Angiolini, S., Basile, M. S., Mazzon, E., & Gugliandolo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813924 · Cited by 2
Gao, X., Zhai, J., He, X., Ding, W., & Shen, B. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117623 · Cited by 2
Lipid Metabolism: Key Determinant in Neurodegenerative Diseases
Yadav, M., Gupta, J., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_6 · Cited by 2
Genetics of Mendelian Forms of Parkinson’s Disease
Lesage, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_1 · Cited by 2
Reconstitution of Motor Protein ATPase
Xuan, M., Jia, Y., & Li, J. (2017) · Springer eBooks · doi:10.1007/978-981-10-6059-5_10 · Cited by 2
Bases moléculaires de la maladie de Parkinson
Lesage, S., & Brice, A. (2010) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(10)51090-x · Cited by 2
Paediatric and adult movement disorders (update)
Morrison, P. J. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2001.0528 · Cited by 2
Autosomal dominant Parkinson’s disease in a large German pedigree
Brüggemann, N., Külper, W., Hagenah, J., Bauer, P. O., Pattaro, C., Tadić, V., Lohnau, T., Winkler, S., Tönnies, H., Sprenger, A., et al. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01621.x · Cited by 2
Pan, L., Wang, Z., Ding, D., Zhu, X., Leng, H., Deng, X., & Xu, Y. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1035377 · Cited by 2
DIAGNÓSTICO GENÉTICO PARA ENFERMEDADES NEURODEGENERATIVAS. UN IMPORTANTE DESAFÍO PARA CHILE
Marcelo Miranda, C., & Leonor Bustamante, C. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.06.007 · Cited by 3
Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function
Blesa, J., Trigo‐Damas, I., Quiroga‐Varela, A., & del Rey, N. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_7 · Cited by 3
Jain, R. S., Khan, I., & Sisodiya, M. S. (2016) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2016.09.002 · Cited by 2
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.